SEC 13F Intelligence

Dean Capital Management / JAZZ

Dean Capital Management’s Jazz Pharmaceuticals PLC Position

Does Dean Capital Management own Jazz Pharmaceuticals PLC (JAZZ)? Yes — 21.2K shares worth $4M (+1.66% of its 13F portfolio) as of Q1 2026, down from 21.2K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
21.2K
% of Portfolio
+1.66%
Quarters Held
10
currently held

Position History JAZZ

Reported value by quarter
Q3 ’23: $1MQ3 ’23Q4 ’23: $1MQ1 ’24: $1MQ1 ’24Q3 ’24: $2MQ4 ’24: $2MQ4 ’24Q1 ’25: $2MQ2 ’25: $2MQ2 ’25Q3 ’25: $3MQ4 ’25: $4MQ4 ’25Q1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202621.2K$4M+1.66%
Q4 202521.2K$4M+1.53%
Q3 202520.5K$3M+1.05%
Q2 202520.5K$2M+0.89%
Q1 202516.5K$2M+0.89%
Q4 202416.1K$2M+0.85%
Q3 202414.0K$2M+0.66%
Q1 202411.9K$1M+0.83%
Q4 202311.9K$1M+0.90%
Q3 202310.0K$1M+0.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dean Capital Management’s full portfolio or all institutional holders of JAZZ.